Events
Fall/Winter 2023-2024 Seminar Schedule
In-person seminars will be held on Wednesdays from 12:15 pm – 1:15 pm CT in Room 1220 MBR III.
If you have any questions or need more information, please contact Tia Patton at: tia.repscher@vanderbilt.edu
January 4: Doug Mitchell, University of Illinois at Urbana-Champaign, “Genomics-Enabled Discovery of New Molecules and Enzymes”
January 10: Peter Scott, University of Michigan, “We are Explorers in Radiochemical Space: Adventures in PET Imaging, Artificial Intelligence and Theranostics”
Cancelled: January 17: Craig Lindsley, Warren Center for Neuroscience Drug Discovery at Vanderbilt University, “CNS Drug Discovery at Vanderbilt”
January 24: Matt Hall, NIH/National Center for Advancing Translational Sciences (NCATS), “Assays to Lead the Way: Drug Discovery at NCATS”
January 31: James Imlay, University of Illinois Urbana-Champaign, “How to Kill Your Neighbor: A Story About Oxidative Stress”
February 2, 2:15 pm: Erin Carlson, University of Minnesota, “Chemical Microbiology: Translation and Control of Bacterial Behavior”
February 6, 2:00 pm: Rolf Müller, Helmholtz Institute for Pharmaceutical Research, Saarland, “Approaches Towards Innovative Anti-Infectives from Microbes”
February 7: Wei Mi, Yale University, “Regulation of Escherichia coli Lipopolysaccharide Synthesis”
February 21: Libin Xu, University of Washington, “Differential Contribution of Lipid Peroxidation Mechanisms to Ferroptosis”
February 28: Jeffrey Rathmell, Vanderbilt University Medical Center, “Immunometabolism and the Microenvironment in T Cell Function”
March 1, 2:15 pm: Pei Zhou, Duke University, “Novel Antibiotics Targeting Lipid A Biosynthesis in Gram-negative Bacteria”
March 6: Mia Huang, Scripps Research, La Jolla, “Taming Glycoconjugate Structure and Interactions in Development and Disease”
March 20: Andrei Osterman, Sanford Burnham Prebys, “Experimental Evolution and Genomics of Antibiotic Resistance”
March 27: Neil Pearson, GlaxoSmithKline, “Chemical Biology Platforms to Drug the Undruggable & Gepotidacin, a Novel Triazaacenaphthylene Bacterial Topoisomerase Inhibitor: Antibacterial Mechanism of Action”
April 3: Heidi Hamm, Vanderbilt University, “Protease Activated Receptor 4: Regulation of Platelet Function and Role in Inflammation”
April 10: Michelle Arkin, University of California-San Francisco, “Chemical Biology Approach to Caspase-6 as a New Target in Alzheimer’s Disease.” Co-sponsored by the Department of Pharmacology.
April 11 3:00 pm: Steven Johnson, University of Indiana Medical School, “Mechanistic Insights and Strategies to Target GroEL and HSP60 Chaperonin Systems for Therapeutic Development”
April 17: John Pascal, Université de Montréal, “Structures and Mechanisms of PARP Family Enzymes”